Aier Eye Hospital Group Co., Ltd. Overview
Pro stress-test →Aier Eye Hospital is China's largest ophthalmology chain, operating 764 eye hospitals and centers across Asia, Europe, and North America. The company generates approximately CNY 22.17B (~$3.07B USD) in trailing twelve-month revenue and serves over 10 million annual outpatient visits in mainland China, providing comprehensive eye care from cataract surgery to myopia correction.
Strategic Profile
Pro stress-test →Aier maintains competitive advantage through massive scale with 50,000+ employees including 9,000 ophthalmologists and optometrists, combined with a tiered hospital network designed for both premium and accessible care. The company has successfully globalized through strategic acquisitions including Clinica Baviera (Europe's largest eye clinic in 2017) and SEC Healthcare in Singapore, establishing three listed entities across China, Spain, and Singapore to capture diverse market opportunities.
Competitive Landscape
Pro stress-test →Aier dominates China's fragmented ophthalmology market as the undisputed leader, with no single competitor matching its scale of 764 facilities. Competition comes from smaller regional chains and independent hospitals, plus international players like Clinica Baviera (now owned by Aier) in Europe. The market shows consolidation trends favoring large players with capital and brand strength, where Aier's first-mover advantage and quality network positioning it well despite governance concerns.
Industry Context
Aier Eye Hospital Group Co., Ltd. operates in Ophthalmology Healthcare / Medical Services.
Key facts
Founded: 2002 · Headquarters: Changsha, China · Employees: 50,000+ · Revenue: CNY 22.17B (~$3.07B) · Market cap: $14.8B